Singapore, April 14 -- The Center for Myokine Convergence Research at Korea University College of Medicine has signed a memorandum of understanding (MoU) with MFC to jointly develop therapeutics for muscle loss in astronauts.

This agreement represents a follow-up collaboration based on the 2022 contract between the two institutions for "technical cooperation in rare and intractable muscle atrophy diseases and technology transfer for sarcopenia therapeutics." Building on accumulated research and development data, the two organizations plan to expand their research scope into the space environment and accelerate the development of next-generation therapeutics for muscle disorders.

Under this agreement, both parties will collaborate in the...